Decibel Cannabis Company Inc.’s (CVE:DB) Stock Is Going Strong: Have Financials A Role To Play?

Decibel Cannabis’ (CVE:DB) stock is up by a considerable 12% over the past month. Given that stock prices are usually aligned with a company’s financial performance in the long-term, we decided to study its financial indicators more closely to see if they had a hand to play in the recent price move. Particularly, we will be paying attention to Decibel Cannabis’ ROE today.

ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company’s shareholders.

Check out our latest analysis for Decibel Cannabis

How Do You Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity

So, based on the above formula, the ROE for Decibel Cannabis is:

2.2% = CA$1.0m ÷ CA$47m (Based on the trailing twelve months to June 2023).

The ‘return’ is the yearly profit. One way to conceptualize this is that for each CA$1 of shareholders’ capital it has, the company made CA$0.02 in profit.

What Has ROE Got To Do With Earnings Growth?

Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Based on how much of its profits the company chooses to reinvest or “retain”, we are then able to evaluate a company’s future ability to generate profits. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don’t necessarily bear these characteristics.

A Side By Side comparison of Decibel Cannabis’ Earnings Growth And 2.2% ROE

As you can see, Decibel Cannabis’ ROE looks pretty weak. Even compared to the average industry ROE of 14%, the company’s ROE is quite dismal. Although, we can see that Decibel Cannabis saw a modest net income growth of 19% over the past five years. We reckon that there could be other factors at play here. For example, it is possible that the company’s management has made some good strategic decisions, or that the company has a low payout ratio.

We then performed a comparison between Decibel Cannabis’ net income growth with the industry, which revealed that the company’s growth is similar to the average industry growth of 21% in the same 5-year period.

past-earnings-growth

Earnings growth is a huge factor in stock valuation. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you’re wondering about Decibel Cannabis”s valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.

Is Decibel Cannabis Making Efficient Use Of Its Profits?

Decibel Cannabis doesn’t pay any dividend, meaning that all of its profits are being reinvested in the business, which explains the fair bit of earnings growth the company has seen.

Summary

On the whole, we do feel that Decibel Cannabis has some positive attributes. Despite its low rate of return, the fact that the company reinvests a very high portion of its profits into its business, no doubt contributed to its high earnings growth. With that said, the latest industry analyst forecasts reveal that the company’s earnings are expected to accelerate. Are these analysts expectations based on the broad expectations for the industry, or on the company’s fundamentals? Click here to be taken to our analyst’s forecasts page for the company.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Author: CSN